Bionyra Pharma Launches with $165 million Oversubscribed Series A to Advance Clinical Stage Pipeline of Next Generation Biologics for Immune-Mediated Inflammatory Diseases

Source Summary

PARIS & BOSTON--(BUSINESS WIRE)-- #Atopicdermatitis--Bionyra raises $165M Series A to advance clinical pipeline of biologics for immune-mediated inflammatory diseases including atopic dermatitis and IBD